{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:42:39Z","timestamp":1780555359538,"version":"3.54.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,11]]},"DOI":"10.7759\/cureus.80397","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:08:19Z","timestamp":1741698499000},"source":"Crossref","is-referenced-by-count":1,"title":["Stage IV Prostate Cancer Presenting With a Low Prostate-Specific Antigen Level: A Case Report"],"prefix":"10.7759","author":[{"given":"Brandon","family":"Weissman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph l","family":"Sarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Pusatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref2","article-title":"Prostate Cancer","author":"Leslie SW","year":"2025","unstructured":"Leslie SW, Soon-Sutton TL, Skelton WP. Prostate Cancer. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1242\/dev.148270","article-title":"Prostate organogenesis: tissue induction, hormonal regulation and cell type specification","volume":"144","author":"Toivanen R","year":"2017","unstructured":"Toivanen R, Shen MM. Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development. 2017, 144:1382-98. 10.1242\/dev.148270","journal-title":"Development"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2015.10.002","article-title":"Cell types of origin for prostate cancer","volume":"37","author":"Lee SH","year":"2015","unstructured":"Lee SH, Shen MM. Cell types of origin for prostate cancer. Curr Opin Cell Biol. 2015, 37:35-41. 10.1016\/j.ceb.2015.10.002","journal-title":"Curr Opin Cell Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89. 10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"ref7","unstructured":"Prostate cancer. screening. (2025). Accessed: February 2, 2025: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prostate-cancer-screening."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2010.51.5.358","article-title":"Progression of prostate cancer despite an extremely low serum level of prostate-specific antigen","volume":"51","author":"Lee DK","year":"2010","unstructured":"Lee DK, Park JH, Kim JH, et al.. Progression of prostate cancer despite an extremely low serum level of prostate-specific antigen. Korean J Urol. 2010, 51:358-61. 10.4111\/kju.2010.51.5.358","journal-title":"Korean J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1023\/b:urol.0000020306.08275.49","article-title":"Metastatic prostate cancer with normal level of serum prostate-specific antigen","volume":"35","author":"Nishio R","year":"2003","unstructured":"Nishio R, Furuya Y, Nagakawa O, Fuse H. Metastatic prostate cancer with normal level of serum prostate-specific antigen. Int Urol Nephrol. 2003, 35:189-92. 10.1023\/b:urol.0000020306.08275.49","journal-title":"Int Urol Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2021.09.014","article-title":"How to treat prostate cancer with androgen deprivation and minimize cardiovascular risk: a therapeutic tightrope","volume":"3","author":"Narayan V","year":"2021","unstructured":"Narayan V, Ross AE, Parikh RB, Nohria A, Morgans AK. How to treat prostate cancer with androgen deprivation and minimize cardiovascular risk: a therapeutic tightrope. JACC CardioOncol. 2021, 3:737-41. 10.1016\/j.jaccao.2021.09.014","journal-title":"JACC CardioOncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346140-stage-iv-prostate-cancer-presenting-with-a-low-prostate-specific-antigen-level-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:08:21Z","timestamp":1741698501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346140-stage-iv-prostate-cancer-presenting-with-a-low-prostate-specific-antigen-level-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.80397","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}